Bominama ApS: Financial statements 2023
CVR: 27743250
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Bominama ApS (CVR 27743250) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -72,400 and a net result of DKK 892,490 compared with DKK -600,524 the year before. Equity in the 2023 report amounted to DKK 13,918,199. The solvency ratio was 98%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -72,400
- Profit/Loss
- DKK 892,490
- Equity
- DKK 13,918,199
- Total Assets
- DKK 14,202,033
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -72K | 892K | 13.9M | 1 |
| 2022 | - | -77K | -601K | 13.1M | 1 |
| 2021 | - | -85K | 1.3M | 13.7M | 1 |
| 2020 | - | -76K | 353K | 12.5M | 1 |
| 2019 | - | -38K | 349K | 14.2M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Bominama ApS
Bominama ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2004. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named TAND- OG IMPLANTATKLINIKKEN FREDERIKSHAVN HOLDING ApS. The management consists of Bodil Diernæs. The company is owned by Bodil Diernæs. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -84,274 and a net result of DKK -1,023,679 compared with DKK 2,047,314 the year before. Equity in the 2025 report amounted to DKK 14,821,934.